Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Sandborn

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Gut|January 2, 2014
Taking a closer look at IBDLaurence J Egan, William Sandborn
Journal of Crohn'S & Colitis|September 24, 2016
Head-to-head Comparative Studies: Challenges and Opportunities?Laurent Peyrin-Biroulet, Anthony Lopez, William Sandborn
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 7, 2016
The Crohn's Disease-Ulcerative Colitis Clinical AppraisalGeert D'Haens, Brian Bressler, Silvio Danese, et al.
Nutrients|April 16, 2020
Galacto-Oligosaccharide RP-G28 Improves Multiple Clinical Outcomes in Lactose-Intolerant PatientsWilliam Chey, William Sandborn, Andrew J Ritter, et al.
Alimentary Pharmacology & Therapeutics|March 21, 2021
Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis-authors' replySushrut Jangi, Hyuk Yoon, Parambir Dulai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2016
The Crohn's Disease-Ulcerative Colitis Clinical Appraisal Update: Emerging Trends in Clinical PracticeWilliam Sandborn, Jean-Frédéric Colombel, Geert D'Haens, et al.
Gastroenterology|October 9, 2007
A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitisScott Plevy, Bruce Salzberg, Gert Van Assche, et al.
Immunohorizons|December 16, 2021
Class Ib MHC-Mediated Immune Interactions Play a Critical Role in Maintaining Mucosal Homeostasis in the Mammalian Large IntestineSuryasarathi Dasgupta, Igor Maricic, Jay Tang, et al.
Gut|February 20, 2016
The safety of vedolizumab for ulcerative colitis and Crohn's diseaseJean-Frédéric Colombel, Bruce E Sands, Paul Rutgeerts, et al.
The New England Journal of Medicine|June 28, 2023
Mirikizumab as Induction and Maintenance Therapy for Ulcerative ColitisGeert D'Haens, Marla Dubinsky, Taku Kobayashi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Gut|January 2, 2014
Taking a closer look at IBDLaurence J Egan, William Sandborn
Journal of Crohn'S & Colitis|September 24, 2016
Head-to-head Comparative Studies: Challenges and Opportunities?Laurent Peyrin-Biroulet, Anthony Lopez, William Sandborn
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 7, 2016
The Crohn's Disease-Ulcerative Colitis Clinical AppraisalGeert D'Haens, Brian Bressler, Silvio Danese, et al.
Nutrients|April 16, 2020
Galacto-Oligosaccharide RP-G28 Improves Multiple Clinical Outcomes in Lactose-Intolerant PatientsWilliam Chey, William Sandborn, Andrew J Ritter, et al.
Alimentary Pharmacology & Therapeutics|March 21, 2021
Letter: the combination of histologic remission and Mayo endoscopic score 1 as a suitable therapeutic target in ulcerative colitis-authors' replySushrut Jangi, Hyuk Yoon, Parambir Dulai, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2016
The Crohn's Disease-Ulcerative Colitis Clinical Appraisal Update: Emerging Trends in Clinical PracticeWilliam Sandborn, Jean-Frédéric Colombel, Geert D'Haens, et al.
Gastroenterology|October 9, 2007
A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitisScott Plevy, Bruce Salzberg, Gert Van Assche, et al.
Immunohorizons|December 16, 2021
Class Ib MHC-Mediated Immune Interactions Play a Critical Role in Maintaining Mucosal Homeostasis in the Mammalian Large IntestineSuryasarathi Dasgupta, Igor Maricic, Jay Tang, et al.
Gut|February 20, 2016
The safety of vedolizumab for ulcerative colitis and Crohn's diseaseJean-Frédéric Colombel, Bruce E Sands, Paul Rutgeerts, et al.
The New England Journal of Medicine|June 28, 2023
Mirikizumab as Induction and Maintenance Therapy for Ulcerative ColitisGeert D'Haens, Marla Dubinsky, Taku Kobayashi, et al.
Pageof 2